Severe asthma at COVID-19 time: what is new on biologic therapies
Minerva Med
.
2021 Feb;112(1):114-117.
doi: 10.23736/S0026-4806.20.06727-0.
Epub 2020 Jun 19.
Authors
Filippo Patrucco
1
2
,
Elisa Villa
3
,
Valentina Foci
4
,
Alida Benfante
5
,
Michela Bellocchia
6
,
Paolo Solidoro
6
7
Affiliations
1
Division of Respiratory Diseases, Department of Medicine, Maggiore della Carità University Hospital, Novara, Italy -
[email protected]
.
2
Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy -
[email protected]
.
3
Unit of Pneumology, A.S.L. Genova3, Villa Scassi Hospital, Genoa, Italy.
4
Unit U of Pneumology, Department of Medicine, A.S.L. Vercelli, Vercelli, Italy.
5
ProMISE Department, University of Palermo, Palermo, Italy.
6
Unit U of Pneumology, Department of Cardiovascular and Thoracic Medicine, Città della Salute e della Scienza, University of Turin, Turin, Italy.
7
Department of Medical Sciences, University of Turin, Turin, Italy.
PMID:
32567824
DOI:
10.23736/S0026-4806.20.06727-0
No abstract available
Publication types
Editorial
MeSH terms
Asthma / complications*
Asthma / therapy*
Biological Therapy*
COVID-19 / complications*
Humans
Severity of Illness Index